Nasdaq
$1.68▼ 2.33%vs prev close
🔒 Quotes & buy pressure are MAX onlySee plans
Market cap $5.2MShares out 3.1M sh
Chart
Filings & news by date
Hover (PC) or tap (mobile) a candle to see that day only
Filings
18- 10.16After-hours26.10.17 06:00DEF 14AOther#●●●
BIOMERICA INC
Biomerica, Inc. will hold its 2026 Annual Meeting of Stockholders on December 11, 2026, to vote on the election of directors, executive compensation, appointment of auditors, and a 150,000-share increase for the 2024 Stock Incentive Plan. As of the record date of October 15, 2026, the company has 4,598,968 shares of common stock outstanding.…more
$1.68-2.33%vs prev closeDetected5m · 30m · 60m · Next dayPLUSView filingShare
- 10.15After-hours26.10.16 06:0010-QEarnings
BIOMERICA INC
Biomerica reported revenue of $1.265 million and a net loss of $1.232 million for the first quarter of fiscal year 2027, ending August 31, 2026. During the quarter, the company raised capital through a private placement of 1,393,705 shares of common stock, and the total shares outstanding as of October 15, 2026, were 4,598,968.…more
$1.68-2.33%vs prev closeView filingShare - 10.15After-hours26.10.16 06:008-KKey event
BIOMERICA INC
David Moatazedi, a member of the Board of Directors of Biomerica, Inc., has decided not to stand for re-election at the company's 2026 Annual Meeting of Stockholders scheduled for December 11, 2026. His decision is not the result of any disagreement with the company or the Board, and he has served as a director since December 2022.…more
$1.68-2.33%vs prev closeView filingShare
17 more filings
Sign up free to unlock the full feed and real-time filing & news alerts.
- ✓Free — no card required
- ✓Full real-time filing & news feed
- ✓Daily Today Report
News
GlobeNewswire- 10.16Pre-market26.10.16 21:19#●●●#●●●
Biomerica Reports Fiscal 2027 First Quarter Financial Results
Biomerica reported weaker financial results with a decline in net sales and an increased operating loss compared to the same period last year. While commercialization efforts for new products are ongoing, the lack of improved profitability warrants a neutral investment outlook.…more
$1.68-2.33%vs prev closeDetected5m · 30m · 60m · Next dayPLUS
- 10.15After-hours26.10.16 07:17
●●●●●●●● ●●●●● ●●●●●●
Biomerica reported Q1 sales of $1.265 million, marking an 8.33% decrease compared to the same period last year. The company also posted a quarterly loss of $0.37 per share.…more
$1.68-2.33%vs prev closeShareBenzinga - 9.25Regular26.09.26 04:01
●●●●●●●● ●●●●● ●●●●●●
Biomerica has filed a shelf registration statement to offer up to $250 million in securities, including common stock, preferred stock, and debt. This filing allows for future capital raises, which may lead to potential shareholder dilution.…more
$1.68-2.33%vs prev closeShareBenzinga
2 more news items
Sign up free to unlock the full feed and real-time filing & news alerts.
- ✓Free — no card required
- ✓Full real-time filing & news feed
- ✓Daily Today Report